Literature DB >> 2329262

Acromegaly and primary amenorrhea: ovulation and pregnancy induced by SMS 201-995 and bromocriptine.

M Montini, G Pagani, D Gianola, M D Pagani, R Piolini, M G Camboni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2329262     DOI： 10.1007/BF03349537

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN： 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  4 in total

1.  SMS 201-995: a very potent and selective octapeptide analogue of somatostatin with prolonged action.

Authors:  W Bauer; U Briner; W Doepfner; R Haller; R Huguenin; P Marbach; T J Petcher
Journal:  Life Sci       Date:  1982-09-13       Impact factor: 5.037

2.  Successful pregnancy in a previously infertile woman treated with SMS-201-995 for acromegaly.

Authors:  A M Landolt; J Schmid; C Wimpfheimer; E R Karlsson; V Boerlin
Journal:  N Engl J Med       Date:  1989-03-09       Impact factor: 91.245

Review 3.  NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.

Authors:  P Gorden; R J Comi; P N Maton; V L Go
Journal:  Ann Intern Med       Date:  1989-01-01       Impact factor: 25.391

4.  Opiate antagonistic properties of an octapeptide somatostatin analog.

Authors:  R Maurer; B H Gaehwiler; H H Buescher; R C Hill; D Roemer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205
  4 in total
  6 in total

1.  Normal pregnancy in a woman with nesidioblastosis treated with somatostatin analog octreotide.

Authors:  C Boulanger; D Vezzosi; A Bennet; F Lorenzini; J Fauvel; P Caron
Journal:  J Endocrinol Invest       Date:  2004-05       Impact factor: 4.256

Review 2.  Medical management of pituitary adenomas: the special case of management of the pregnant woman.

Authors:  Marcello Delano Bronstein; Luiz Roberto Salgado; Nina Rosa de Castro Musolino
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

Review 3.  A risk-benefit assessment of octreotide in the treatment of acromegaly.

Authors:  A J van der Lely; W W de Herder; S W Lamberts
Journal:  Drug Saf       Date:  1997-11       Impact factor: 5.606

Review 4.  Pregnancy and acromegaly: a review.

Authors:  Vicky Cheng; Charles Faiman; Laurence Kennedy; Fadi Khoury; Betul Hatipoglu; Robert Weil; Amir Hamrahian
Journal:  Pituitary       Date:  2012-03       Impact factor: 4.107

Review 5.  First-generation somatostatin receptor ligands and pregnancy: lesson from women with acromegaly.

Authors:  Magaly Vialon; Solange Grunenwald; Céline Mouly; Delphine Vezzosi; Antoine Bennet; Philippe Caron
Journal:  Endocrine       Date:  2020-07-30       Impact factor: 3.633

Review 6.  Preconception counselling for women with acromegaly: More questions than answers.

Authors:  Angela Assal; Janine Malcolm; Heather Lochnan; Erin Keely
Journal:  Obstet Med       Date:  2015-09-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.